Sign in
CompletedNo phase

Optimizing the Influenza Clinical Decision Support Tool

Key facts

Who runs it
NYU Langone Health
Where
New York, United StatesSee the site
Trial code
Status
Completed
People taking part
25,881 people enrolled
Started
16 Jan 2018
Ended
21 Nov 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Current Version of the Influenza Alert
  • Alternate Modifications of the Influenza Alert
Record updated
1 April 2024

Who can take part

Age
3 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool

Who cannot take part

  • N/A

Where in United States

  • New York University School of MedicineNew York, United States

About the trial

What the trial wants to find out

The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.

The 2 groups in the trial

  • Usual CareExisting treatment, for comparison

    The current version of the alert will fire for this arm of the study.

    Treatment: Current Version of the Influenza Alert

  • Alert IterationExisting treatment, for comparison

    A modified version of the alert will fire for this arm of the study.

    Treatment: Alternate Modifications of the Influenza Alert

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
1 April 2024